News
-
TGA feedback flowing
Friday | Jun 29 2018MORE than 2,000 stakeholders have given feedback to the Therapeutic Goods Administration (TGA) via the 2018 Stakeholder Surveys.
-
THC to link with Canada’s Ascent
Friday | Jun 29 2018ASX-LISTED The Hydroponics Company (THC) has signed a Letter of Intent with Canada's Ascent Industries to share both product and knowledge to collaboratively grow both businesses.
-
Guild, MA welcome med shortages bill
Friday | Jun 29 2018BOTH the Pharmacy Guild of Australia and Medicines Australia (MA) have welcomed the legislation yesterday to make reporting of medicine shortages mandatory.
-
More fake sildenafil
Friday | Jun 29 2018THE Therapeutic Goods Administration (TGA) has issued Safety Advisory notices about three counterfeit sildenafil brands that have entered Australia.
-
Dispensary Corner
Friday | Jun 29 2018
29 Jun 18CHANGE of address: police in Delaware's capital city Dover, US, would like to know who dropped a house onto a two-lane road.
-
TBN celebrates 38% growth
Thursday | Jun 28 2018TBN'S Jun pharmacy and health conference heard ceo Tony Rechtman (pictured with guest speaker Married At First Sight's Sarah Roza), announce that the company had recorded growth of 38% over last year, more than 17 times the industry average growth for cosmetics in Australia alone.
-
Medicinal cannabis facility
Thursday | Jun 28 2018LISTED medicinal cannabis company Cann Group has announced it has signed a heads of agreement with Australia Pacific Airports Melbourne (APAM), securing the site of Cann's proposed Stage 3 medicinal cannabis cultivation and GMP manufacturing facility.
-
THC appointment
Thursday | Jun 28 2018ASX-LISTED The Hydroponics Company (THC) has appointed Katy Williams Day as Product and Regulatory Affairs manager in THC Pharma, a wholly owned subsidiary of THC.
-
Rare cancer research
Thursday | Jun 28 2018THE Federal Government will provide $33 million to Australian researchers to continue the fight against rare cancers and rare diseases, giving hope to thousands of patients.
-
Botanix acne trial tick
Thursday | Jun 28 2018LISTED medical dermatology company Botanix Pharmaceuticals has announced the recruitment of first patients for its BTX 1503 Phase 2 acne clinical trial, following recent regulatory approvals and the earlier successful Phase 1b results.
